Fibroblast Growth Factor Signaling Potentiates VE-Cadherin Stability at Adherens Junctions by Regulating SHP2

• Kunihiko Hatanaka,

  Current address: Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

  Affiliation Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Anthony A. Lanahan,

  Affiliation Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Masahiro Murakami ,

  Contributed equally to this work with: Masahiro Murakami, Michael Simons

  * E-mail: Masahiro.Murakami@Yale.edu

  Affiliation Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Michael Simons

  Contributed equally to this work with: Masahiro Murakami, Michael Simons

  Affiliations Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯